Improving cervical cancer screening methods
NCI Moonshot: Accelerate Cervical Cancer Control
This study is working on new ways to test for cervical cancer that can be used in all kinds of places, aiming to make screening easier and more accurate for everyone, so patients can get the care they need sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11042043 on NIH RePORTER |
What this research studies
This research focuses on developing innovative technologies for cervical cancer screening that can be used in both high- and low-resource settings. It involves analyzing over 200,000 clinical samples to understand HPV genotyping and conducting routine testing of host and viral methylation assays on more than 50,000 specimens. The goal is to enhance cervical cancer control through better screening methods that are accessible to diverse populations. Patients may benefit from more accurate and efficient screening processes that could lead to earlier detection and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing cervical cancer screening, particularly those in both high- and low-resource settings.
Not a fit: Patients who have already been diagnosed with advanced cervical cancer may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cervical cancer screening methods, resulting in earlier detection and better outcomes for patients.
How similar studies have performed: Previous research has shown success in developing new screening technologies for cervical cancer, indicating that this approach has potential for impactful results.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Freedman, Leonard — Leidos Biomedical Research, INC.
- Study coordinator: Freedman, Leonard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.